Litcius/Paper detail

Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

Brad H. Rovin, Y K Onno Teng, Ellen M. Ginzler, Cristina Arriens, Dawn J. Caster, Juanita Romero‐Díaz, Keisha L. Gibson, Joshua M. Kaplan, Laura Lisk, Sandra Navarra, Samir V. Parikh, Simrat Randhawa, Neil Solomons, Robert B. Huizinga

2021The Lancet594 citationsDOI

Topics & Concepts

MedicineLupus nephritisInternal medicineRenal functionPlaceboClinical endpointPrednisoneGastroenterologySystemic lupus erythematosusCreatinineClinical trialPathologyDiseaseAlternative medicineSystemic Lupus Erythematosus ResearchRenal Transplantation Outcomes and TreatmentsCytomegalovirus and herpesvirus research
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial | Litcius